Vir Biotechnology Inc (OQ:VIR)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for VIR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 27/20 Feb 25/20 Horn Howard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 60,000  
Dec 12/19 Dec 10/19 Ramasastry Saira Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 57,777  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series B Convertible Preferred Stock C - Conversion -2,222,222  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series B Convertible Preferred Stock C - Conversion -555,555  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series A-1 Convertible Preferred Stock C - Conversion -13,333,332  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series A-1 Convertible Preferred Stock C - Conversion -11,111,110  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Common Stock P - Open market or private purchase 1,000,000 $20.00
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Common Stock C - Conversion 15,555,554  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Common Stock C - Conversion 11,666,665  
Oct 18/19 Oct 16/19 Nelsen Robert Indirect Ownership Series B Convertible Preferred Stock C - Conversion -2,222,222  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for VIR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 27/20 Feb 25/20 Horn Howard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 60,000  
Dec 12/19 Dec 10/19 Ramasastry Saira Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 57,777  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series B Convertible Preferred Stock C - Conversion -2,222,222  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series B Convertible Preferred Stock C - Conversion -555,555  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series A-1 Convertible Preferred Stock C - Conversion -13,333,332  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Series A-1 Convertible Preferred Stock C - Conversion -11,111,110  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Common Stock P - Open market or private purchase 1,000,000 $20.00
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Common Stock C - Conversion 15,555,554  
Oct 18/19 Oct 16/19 Burow Kristina Indirect Ownership Common Stock C - Conversion 11,666,665  
Oct 18/19 Oct 16/19 Nelsen Robert Indirect Ownership Series B Convertible Preferred Stock C - Conversion -2,222,222  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $VIR

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Precigen (OQ:PGEN)